Voya Investment Management LLC raised its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 13.4% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 422,477 shares of the real estate investment trust's stock after purchasing an additional 49,884 shares during the quarter. Voya Investment Management LLC owned about 0.18% of Sabra Healthcare REIT worth $7,381,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in the stock. Strs Ohio acquired a new position in shares of Sabra Healthcare REIT in the 1st quarter valued at $777,000. Advisors Capital Management LLC boosted its holdings in shares of Sabra Healthcare REIT by 20.5% in the 1st quarter. Advisors Capital Management LLC now owns 2,232,609 shares of the real estate investment trust's stock valued at $39,004,000 after purchasing an additional 380,505 shares during the last quarter. Intech Investment Management LLC boosted its holdings in shares of Sabra Healthcare REIT by 8.4% in the 1st quarter. Intech Investment Management LLC now owns 245,415 shares of the real estate investment trust's stock valued at $4,287,000 after purchasing an additional 18,915 shares during the last quarter. Focus Partners Wealth boosted its holdings in shares of Sabra Healthcare REIT by 11.4% in the 1st quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust's stock valued at $404,000 after purchasing an additional 2,375 shares during the last quarter. Finally, Anchor Investment Management LLC acquired a new position in shares of Sabra Healthcare REIT in the 1st quarter valued at $58,000. Institutional investors and hedge funds own 99.40% of the company's stock.
Analyst Upgrades and Downgrades
Several equities analysts recently weighed in on SBRA shares. JMP Securities lifted their target price on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a report on Wednesday, August 6th. BMO Capital Markets lifted their target price on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a report on Monday, August 25th. Scotiabank lifted their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a report on Monday, June 23rd. Wells Fargo & Company lifted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a report on Wednesday, August 27th. Finally, Truist Financial lifted their target price on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a "hold" rating in a report on Tuesday, September 2nd. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, Sabra Healthcare REIT has an average rating of "Moderate Buy" and a consensus price target of $20.83.
Check Out Our Latest Stock Report on Sabra Healthcare REIT
Sabra Healthcare REIT Stock Down 0.8%
SBRA stock traded down $0.15 during trading on Friday, reaching $18.71. The stock had a trading volume of 3,923,838 shares, compared to its average volume of 2,059,766. Sabra Healthcare REIT, Inc. has a 1-year low of $15.60 and a 1-year high of $20.03. The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 0.91. The company has a market capitalization of $4.49 billion, a P/E ratio of 24.62, a PEG ratio of 1.49 and a beta of 0.88. The firm has a fifty day moving average price of $18.73 and a 200 day moving average price of $18.06.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The firm had revenue of $189.15 million for the quarter, compared to analyst estimates of $185.64 million. During the same quarter in the previous year, the business posted $0.36 EPS. The firm's revenue was up 7.4% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, equities analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.
Sabra Healthcare REIT Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Friday, August 15th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.4%. Sabra Healthcare REIT's payout ratio is presently 157.89%.
Sabra Healthcare REIT Company Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Recommended Stories

Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.